CO205 Evaluating Disease-Free Survival (DFS) As a Surrogate Endpoint (SE) for Overall Survival (OS) in Muscle-Invasive Urothelial Carcinoma (MIUC): An Analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare Data
Abstract
Authors
L. Leung S. Kanters M.M. Pourrahmat H.S. Friedman P. Navaratnam G. Reardon M.Y. Patel S. Teitsson M. Kurt Y. Lotan